Table 1 Baseline clinical demographics of the study population

Age (years)

75.2±7.7

Female

21 (29.2)

BMI (kg/m²)

29.4±8.7

Diabetes mellitus

27 (37.5)

Hypertension

62 (86.1)

Peripheral artery disease

9 (12.5)

Coronary artery disease

32 (44.4)

Prior myocardial infarction

8 (11.1)

Prior CABG

13 (18.1)

Heart failure history

13 (18.1)

Prior stroke/TIA

26 (36.1)

 Persistent/Permanent

38 (52.8)

 Paroxysmal

34 (47.2)

CHA₂DS₂VASc score

4.3±1.6

HASBLED score

3.7±0.9

LVEF (%)

59.5 [50-60]

Reduced LVEF (<40%)

11 (15.3)

Intraprocedural contrast administration (ml)

82.0 [59-113]